- IBDEI2TR ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,45054,2)
- ;;=^5009226
- ;;^UTILITY(U,$J,358.3,45055,0)
- ;;=L27.0^^170^2245^37
- ;;^UTILITY(U,$J,358.3,45055,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45055,1,3,0)
- ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
- ;;^UTILITY(U,$J,358.3,45055,1,4,0)
- ;;=4^L27.0
- ;;^UTILITY(U,$J,358.3,45055,2)
- ;;=^5009144
- ;;^UTILITY(U,$J,358.3,45056,0)
- ;;=L27.1^^170^2245^38
- ;;^UTILITY(U,$J,358.3,45056,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45056,1,3,0)
- ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
- ;;^UTILITY(U,$J,358.3,45056,1,4,0)
- ;;=4^L27.1
- ;;^UTILITY(U,$J,358.3,45056,2)
- ;;=^5009145
- ;;^UTILITY(U,$J,358.3,45057,0)
- ;;=L51.1^^170^2245^44
- ;;^UTILITY(U,$J,358.3,45057,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45057,1,3,0)
- ;;=3^Stevens-Johnson Syndrome
- ;;^UTILITY(U,$J,358.3,45057,1,4,0)
- ;;=4^L51.1
- ;;^UTILITY(U,$J,358.3,45057,2)
- ;;=^336636
- ;;^UTILITY(U,$J,358.3,45058,0)
- ;;=L51.3^^170^2245^45
- ;;^UTILITY(U,$J,358.3,45058,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45058,1,3,0)
- ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
- ;;^UTILITY(U,$J,358.3,45058,1,4,0)
- ;;=4^L51.3
- ;;^UTILITY(U,$J,358.3,45058,2)
- ;;=^336637
- ;;^UTILITY(U,$J,358.3,45059,0)
- ;;=Z12.83^^170^2245^21
- ;;^UTILITY(U,$J,358.3,45059,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45059,1,3,0)
- ;;=3^Screening for Malig Neop of Skin
- ;;^UTILITY(U,$J,358.3,45059,1,4,0)
- ;;=4^Z12.83
- ;;^UTILITY(U,$J,358.3,45059,2)
- ;;=^5062696
- ;;^UTILITY(U,$J,358.3,45060,0)
- ;;=Z48.817^^170^2245^48
- ;;^UTILITY(U,$J,358.3,45060,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45060,1,3,0)
- ;;=3^Surgical Aftercare Following Skin Surgery
- ;;^UTILITY(U,$J,358.3,45060,1,4,0)
- ;;=4^Z48.817
- ;;^UTILITY(U,$J,358.3,45060,2)
- ;;=^5063054
- ;;^UTILITY(U,$J,358.3,45061,0)
- ;;=L94.0^^170^2245^20
- ;;^UTILITY(U,$J,358.3,45061,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45061,1,3,0)
- ;;=3^Scleroderma,Localized
- ;;^UTILITY(U,$J,358.3,45061,1,4,0)
- ;;=4^L94.0
- ;;^UTILITY(U,$J,358.3,45061,2)
- ;;=^5009470
- ;;^UTILITY(U,$J,358.3,45062,0)
- ;;=D23.9^^170^2245^22
- ;;^UTILITY(U,$J,358.3,45062,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45062,1,3,0)
- ;;=3^Sebaceous Hyperplasia
- ;;^UTILITY(U,$J,358.3,45062,1,4,0)
- ;;=4^D23.9
- ;;^UTILITY(U,$J,358.3,45062,2)
- ;;=^5002076
- ;;^UTILITY(U,$J,358.3,45063,0)
- ;;=L21.9^^170^2245^23
- ;;^UTILITY(U,$J,358.3,45063,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45063,1,3,0)
- ;;=3^Seborrhea,Unspec
- ;;^UTILITY(U,$J,358.3,45063,1,4,0)
- ;;=4^L21.9
- ;;^UTILITY(U,$J,358.3,45063,2)
- ;;=^188703
- ;;^UTILITY(U,$J,358.3,45064,0)
- ;;=L91.8^^170^2245^39
- ;;^UTILITY(U,$J,358.3,45064,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45064,1,3,0)
- ;;=3^Skin Tag
- ;;^UTILITY(U,$J,358.3,45064,1,4,0)
- ;;=4^L91.8
- ;;^UTILITY(U,$J,358.3,45064,2)
- ;;=^5009460
- ;;^UTILITY(U,$J,358.3,45065,0)
- ;;=I83.12^^170^2245^43
- ;;^UTILITY(U,$J,358.3,45065,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45065,1,3,0)
- ;;=3^Stasis Dermatitis.Left Leg
- ;;^UTILITY(U,$J,358.3,45065,1,4,0)
- ;;=4^I83.12
- ;;^UTILITY(U,$J,358.3,45065,2)
- ;;=^5007989
- ;;^UTILITY(U,$J,358.3,45066,0)
- ;;=I83.11^^170^2245^42
- ;;^UTILITY(U,$J,358.3,45066,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45066,1,3,0)
- ;;=3^Stasis Dermatitis,Right Leg
- ;;^UTILITY(U,$J,358.3,45066,1,4,0)
- ;;=4^I83.11
- ;;^UTILITY(U,$J,358.3,45066,2)
- ;;=^5007988
- ;;^UTILITY(U,$J,358.3,45067,0)
- ;;=C84.19^^170^2245^26
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2TR 3797 printed Feb 19, 2025@00:02:06 Page 2
- IBDEI2TR ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,45054,2)
- +2 ;;=^5009226
- +3 ;;^UTILITY(U,$J,358.3,45055,0)
- +4 ;;=L27.0^^170^2245^37
- +5 ;;^UTILITY(U,$J,358.3,45055,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,45055,1,3,0)
- +8 ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
- +9 ;;^UTILITY(U,$J,358.3,45055,1,4,0)
- +10 ;;=4^L27.0
- +11 ;;^UTILITY(U,$J,358.3,45055,2)
- +12 ;;=^5009144
- +13 ;;^UTILITY(U,$J,358.3,45056,0)
- +14 ;;=L27.1^^170^2245^38
- +15 ;;^UTILITY(U,$J,358.3,45056,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,45056,1,3,0)
- +18 ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
- +19 ;;^UTILITY(U,$J,358.3,45056,1,4,0)
- +20 ;;=4^L27.1
- +21 ;;^UTILITY(U,$J,358.3,45056,2)
- +22 ;;=^5009145
- +23 ;;^UTILITY(U,$J,358.3,45057,0)
- +24 ;;=L51.1^^170^2245^44
- +25 ;;^UTILITY(U,$J,358.3,45057,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,45057,1,3,0)
- +28 ;;=3^Stevens-Johnson Syndrome
- +29 ;;^UTILITY(U,$J,358.3,45057,1,4,0)
- +30 ;;=4^L51.1
- +31 ;;^UTILITY(U,$J,358.3,45057,2)
- +32 ;;=^336636
- +33 ;;^UTILITY(U,$J,358.3,45058,0)
- +34 ;;=L51.3^^170^2245^45
- +35 ;;^UTILITY(U,$J,358.3,45058,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,45058,1,3,0)
- +38 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
- +39 ;;^UTILITY(U,$J,358.3,45058,1,4,0)
- +40 ;;=4^L51.3
- +41 ;;^UTILITY(U,$J,358.3,45058,2)
- +42 ;;=^336637
- +43 ;;^UTILITY(U,$J,358.3,45059,0)
- +44 ;;=Z12.83^^170^2245^21
- +45 ;;^UTILITY(U,$J,358.3,45059,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,45059,1,3,0)
- +48 ;;=3^Screening for Malig Neop of Skin
- +49 ;;^UTILITY(U,$J,358.3,45059,1,4,0)
- +50 ;;=4^Z12.83
- +51 ;;^UTILITY(U,$J,358.3,45059,2)
- +52 ;;=^5062696
- +53 ;;^UTILITY(U,$J,358.3,45060,0)
- +54 ;;=Z48.817^^170^2245^48
- +55 ;;^UTILITY(U,$J,358.3,45060,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,45060,1,3,0)
- +58 ;;=3^Surgical Aftercare Following Skin Surgery
- +59 ;;^UTILITY(U,$J,358.3,45060,1,4,0)
- +60 ;;=4^Z48.817
- +61 ;;^UTILITY(U,$J,358.3,45060,2)
- +62 ;;=^5063054
- +63 ;;^UTILITY(U,$J,358.3,45061,0)
- +64 ;;=L94.0^^170^2245^20
- +65 ;;^UTILITY(U,$J,358.3,45061,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,45061,1,3,0)
- +68 ;;=3^Scleroderma,Localized
- +69 ;;^UTILITY(U,$J,358.3,45061,1,4,0)
- +70 ;;=4^L94.0
- +71 ;;^UTILITY(U,$J,358.3,45061,2)
- +72 ;;=^5009470
- +73 ;;^UTILITY(U,$J,358.3,45062,0)
- +74 ;;=D23.9^^170^2245^22
- +75 ;;^UTILITY(U,$J,358.3,45062,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,45062,1,3,0)
- +78 ;;=3^Sebaceous Hyperplasia
- +79 ;;^UTILITY(U,$J,358.3,45062,1,4,0)
- +80 ;;=4^D23.9
- +81 ;;^UTILITY(U,$J,358.3,45062,2)
- +82 ;;=^5002076
- +83 ;;^UTILITY(U,$J,358.3,45063,0)
- +84 ;;=L21.9^^170^2245^23
- +85 ;;^UTILITY(U,$J,358.3,45063,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,45063,1,3,0)
- +88 ;;=3^Seborrhea,Unspec
- +89 ;;^UTILITY(U,$J,358.3,45063,1,4,0)
- +90 ;;=4^L21.9
- +91 ;;^UTILITY(U,$J,358.3,45063,2)
- +92 ;;=^188703
- +93 ;;^UTILITY(U,$J,358.3,45064,0)
- +94 ;;=L91.8^^170^2245^39
- +95 ;;^UTILITY(U,$J,358.3,45064,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,45064,1,3,0)
- +98 ;;=3^Skin Tag
- +99 ;;^UTILITY(U,$J,358.3,45064,1,4,0)
- +100 ;;=4^L91.8
- +101 ;;^UTILITY(U,$J,358.3,45064,2)
- +102 ;;=^5009460
- +103 ;;^UTILITY(U,$J,358.3,45065,0)
- +104 ;;=I83.12^^170^2245^43
- +105 ;;^UTILITY(U,$J,358.3,45065,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,45065,1,3,0)
- +108 ;;=3^Stasis Dermatitis.Left Leg
- +109 ;;^UTILITY(U,$J,358.3,45065,1,4,0)
- +110 ;;=4^I83.12
- +111 ;;^UTILITY(U,$J,358.3,45065,2)
- +112 ;;=^5007989
- +113 ;;^UTILITY(U,$J,358.3,45066,0)
- +114 ;;=I83.11^^170^2245^42
- +115 ;;^UTILITY(U,$J,358.3,45066,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,45066,1,3,0)
- +118 ;;=3^Stasis Dermatitis,Right Leg
- +119 ;;^UTILITY(U,$J,358.3,45066,1,4,0)
- +120 ;;=4^I83.11
- +121 ;;^UTILITY(U,$J,358.3,45066,2)
- +122 ;;=^5007988
- +123 ;;^UTILITY(U,$J,358.3,45067,0)
- +124 ;;=C84.19^^170^2245^26